美股市場個股詳情
REGN 再生元製藥公司
- 937.610
- +34.130+3.78%
收盤價 05/02 16:00 (美東)
- 912.300
- -25.310-2.70%
盤後 19:30 (美東)
1033.11億總市值27.68市盈率TTM
943.770最高價891.300最低價106.70萬股成交量900.000今開903.480昨收9.92億成交額1.01%換手率26.97市盈率(靜)1.10億總股本998.32552周最高3.83市淨率988.96億流通值684.80552周最低--股息TTM1.05億流通股998.325歷史最高--股息率TTM5.81%振幅4.610歷史最低929.589平均價1股每手
關於再生元製藥公司公司
再生元製藥公司是一家從事藥物發現、發明、開發、製造和商業化的生物技術公司。其產品組合包括以下品牌:EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST和ZALTRAP。該公司通過其專有的VelociSuite技術加速了傳統藥物的開發過程，例如VelocImmune，該技術使用獨特的基因人源化小鼠來生產優化的全人抗體和雙特異性抗體。
公司介紹
公司代碼REGN
公司名稱再生元製藥公司
上市日期1991/04/02
發行價格22.00
成立日期1988
CEODr. Leonard S. Schleifer,M.D.,PhD
所屬市場納斯達克
員工數量13450
證券類型海外普通股
年結日12-31
公司地址777 Old Saw Mill River Road
城市Tarrytown
省份紐約州
國家美國
郵編10591-6707
電話1-914-847-7000
董事高管
- 姓名
- 職務
- 年薪
- Dr. Leonard S. Schleifer,M.D.,PhD
- Co-Chairman of the Board, Co-President and Chief Executive Officer
- 818.43萬
- Dr. George D. Yancopoulos,M.D.,PhD
- Co-Chairman of the Board, Co-President and Chief Scientific Officer
- 775.98萬
- Christopher R. Fenimore
- Senior Vice President, Finance and Chief Financial Officer
- --
- Daniel P. Van Plew
- Executive Vice President and General Manager, Industrial Operations and Product Supply
- 876.01萬
- Jason Pitofsky
- Vice President and Controller
- --
- Joseph J. Larosa
- Executive Vice President, General Counsel and Secretary
- --
- Marion McCourt
- Executive Vice President, Commercial
- --
- Dr. Neil Stahl,PhD
- Executive Vice President, Research and Development
- --
- Andrew J Murphy
- Executive Vice President, Research
- 842.93萬
- Kathryn Guarini, PhD
- Director
- 103.12萬
- Dr. David P. Schenkein, M.D.
- Director
- 103.12萬
- Dr. Huda Y. Zoghbi, M.D.
- Independent Director
- 71.50萬
- Dr. Joseph L. Goldstein,M.D.
- Independent Director
- 71.00萬
- Arthur Frederick Ryan
- Independent Director
- 72.50萬
- Dr. Michael S. Brown, M.D.
- Independent Director
- 72.90萬
- Dr. Craig B. Thompson,M.D.
- Independent Director
- 24.78萬
- Dr. Bonnie L. Bassler, PhD
- Independent Director
- 71.00萬
- Christine A. Poon
- Lead Independent Director
- 74.80萬
- Dr. N. Anthony Coles, M.D.
- Independent Director
- 70.50萬
- George L. Sing
- Independent Director
- 72.50萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅